Seizert Capital Partners LLC Sells 1,103 Shares of Markel Group Inc. $MKL

Seizert Capital Partners LLC cut its stake in shares of Markel Group Inc. (NYSE:MKL) by 21.1% during the third quarter, HoldingsChannel.com reports. The fund owned 4,133 shares of the insurance provider’s stock after selling 1,103 shares during the quarter. Seizert Capital Partners LLC’s holdings in Markel Group were worth $7,900,000 at the end of the most recent quarter.

A number of other institutional investors have also added to or reduced their stakes in the business. Vanguard Group Inc. lifted its stake in shares of Markel Group by 0.8% during the 2nd quarter. Vanguard Group Inc. now owns 1,167,813 shares of the insurance provider’s stock worth $2,332,543,000 after purchasing an additional 9,303 shares during the last quarter. Select Equity Group L.P. boosted its holdings in shares of Markel Group by 75.9% in the 2nd quarter. Select Equity Group L.P. now owns 336,369 shares of the insurance provider’s stock valued at $671,850,000 after acquiring an additional 145,146 shares during the last quarter. DAVENPORT & Co LLC raised its stake in shares of Markel Group by 0.7% during the 2nd quarter. DAVENPORT & Co LLC now owns 204,702 shares of the insurance provider’s stock valued at $408,364,000 after buying an additional 1,383 shares during the last quarter. Norges Bank acquired a new stake in shares of Markel Group during the 2nd quarter worth approximately $288,361,000. Finally, Epoch Investment Partners Inc. lifted its position in shares of Markel Group by 5.8% during the 2nd quarter. Epoch Investment Partners Inc. now owns 114,263 shares of the insurance provider’s stock valued at $228,224,000 after buying an additional 6,244 shares in the last quarter. Hedge funds and other institutional investors own 77.12% of the company’s stock.

Markel Group Stock Up 0.9%

NYSE MKL opened at $2,077.24 on Tuesday. The stock has a market cap of $26.19 billion, a PE ratio of 12.95 and a beta of 0.80. Markel Group Inc. has a fifty-two week low of $1,621.89 and a fifty-two week high of $2,207.59. The company has a quick ratio of 0.60, a current ratio of 0.60 and a debt-to-equity ratio of 0.24. The business has a 50 day moving average price of $2,107.47 and a two-hundred day moving average price of $2,006.19.

Markel Group (NYSE:MKL) last issued its quarterly earnings results on Wednesday, October 29th. The insurance provider reported $30.90 EPS for the quarter, topping the consensus estimate of $22.77 by $8.13. The business had revenue of $3.93 billion for the quarter, compared to analysts’ expectations of $3.77 billion. Markel Group had a net margin of 12.99% and a return on equity of 7.76%. As a group, sell-side analysts predict that Markel Group Inc. will post 96.25 EPS for the current fiscal year.

Insider Transactions at Markel Group

In other news, CEO Simon Wilson sold 75 shares of the stock in a transaction on Tuesday, November 25th. The stock was sold at an average price of $2,072.94, for a total value of $155,470.50. Following the completion of the transaction, the chief executive officer owned 1,770 shares of the company’s stock, valued at approximately $3,669,103.80. This represents a 4.07% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Steven A. Markel sold 1,330 shares of the stock in a transaction on Thursday, December 11th. The shares were sold at an average price of $2,119.12, for a total value of $2,818,429.60. Following the completion of the transaction, the director owned 60,368 shares of the company’s stock, valued at $127,927,036.16. This trade represents a 2.16% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 1,575 shares of company stock valued at $3,330,900 over the last three months. 1.66% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

A number of research firms have recently issued reports on MKL. Cowen restated a “hold” rating on shares of Markel Group in a research report on Tuesday, October 7th. Zacks Research upgraded shares of Markel Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, December 19th. Finally, Weiss Ratings reissued a “buy (b+)” rating on shares of Markel Group in a research report on Monday, December 29th. One analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $2,025.00.

Markel Group Profile

Markel Group (NYSE: MKL) is a diversified insurance holding company best known for underwriting specialty insurance products. Founded in 1930 and headquartered in Richmond, Virginia, the company provides a wide range of commercial property and casualty coverages tailored to niche and hard-to-place risks. Its underwriting operations focus on specialty lines across multiple industries, delivering customized policy structures, program administration, and claims management services for complex exposures.

In addition to primary specialty insurance, Markel operates reinsurance and alternative risk-transfer activities and manages invested assets derived from underwriting float.